1. bookVolume 56 (2017): Edition 3 (January 2017)
Détails du magazine
License
Format
Magazine
eISSN
2545-3149
Première parution
01 Mar 1961
Périodicité
4 fois par an
Langues
Anglais, Polonais
Accès libre

Susceptibility of spirochetes Borreliaburgdorferisensulato to antibiotics in vitro

Publié en ligne: 22 May 2019
Volume & Edition: Volume 56 (2017) - Edition 3 (January 2017)
Pages: 335 - 339
Reçu: 01 Jan 2017
Accepté: 01 Mar 2017
Détails du magazine
License
Format
Magazine
eISSN
2545-3149
Première parution
01 Mar 1961
Périodicité
4 fois par an
Langues
Anglais, Polonais

Aguero-Rosenfeld M.E., Wang G., Swartz I., Wormer G.P.: Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev.18, 484–509 (2005)10.1128/CMR.18.3.484-509.2005119597016020686Search in Google Scholar

Ates L., Hansen-Hübner C., Norris D.E. Richter D., Kraiczy P., Hunfeld K.-P.: Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borreliaburgdorferi. Ticks Tick Borne Dis.1, 30–34 (2010)Search in Google Scholar

BrouquiP., Badiaga S., Raoult D.: Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin. Anti- microb. Agents Chemother. 40, 1552–1554 (1996)10.1128/AAC.40.6.15521633688726038Search in Google Scholar

Chmielewski T., Tylewska-Wierzbanowska S.: Interaction between Borrelia burgdorferi and mouse fibroblasts. Pol. J. Microbiol. 59, 157–160 (2010)Search in Google Scholar

Comstock L.E., Thomas D.D.: Penetration of endothelial cell monolayers by Borrelia burgdorferi. Infect. Immun.57, 1626– 1628 (1989)10.1128/iai.57.5.1626-1628.19893133252707862Search in Google Scholar

Feng J., Wang T., Shi W., Zhang S., Sullivan D., Auwaerter P. G., Zhang Y.: Identification of novel activity against Borrelia burgdorferipersisters using an FDA approved drug library. Emerg. Microbes Infect. 3, e49 (2014)10.1038/emi.2014.53412618126038747Search in Google Scholar

Feng J., Auwaerter P.G., Zhang Y.: Drug combination against Borrelia burgdorferipersisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline. PLoS ONE, 10, e0117207 (2015)10.1371/journal.pone.0117207437381925806811Search in Google Scholar

Feng J., Zhang S., Shi W., Zhang Y.: Ceftriaxone pulse dosing fails to eradicate bio-like microcolonyB. burgdorferi persisters which are sterilized by daptomycin/doxycycline/cefuroxime without pulse dosing. Front. Microbiol.7, 1744 (2016)10.3389/fmicb.2016.01744509512427867375Search in Google Scholar

Hunfeld K.-P., Kraiczy P., Wichelhause T.A., Schäfer V., Brade V.: Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglicosides against Borrelia burgdorferi isolates. Intern. J. Med. Microbiol. 15, 11–17 (2000)Search in Google Scholar

Hunfeld K.-P., Brade V.: Antimicrobial susceptibility of Borrelia burgdorferi sensulato: what we know, what we don’t known, and what we need to know. Wien. Klin. Wochenschr.22, 659–668 (2006)10.1007/s00508-006-0693-z17160604Search in Google Scholar

Hunfeld K.-P., Ruzic-Subljic E., Norris D. E., Kraiczy P., Strle F.: In vitro susceptibility testing of Borrelia burgdorferisensulato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Antimicrob. Agents Chemother. 49, 1294–1301 (2005)10.1128/AAC.49.4.1294-1301.2005106861215793100Search in Google Scholar

Hunfeld K.-P., Ruzic-Subljic E., Norris D. E., Kraiczy P., Strle F.: Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance. Intern. J. Med. Microbiol. 296 Suppl. 40, 233–241 (2006)Search in Google Scholar

Kraiczy P., Weigand J., Wichelhaus T. A., Heising P., Backes H., Schafer V., Acker G., Brade V., Hunfeld K.-P.: In vitro activities of fluorochinolones against the spirochete Borrelia burgdorferi. Antimcrob. Agents Chemiother. 45, 2486–2494 (2001)10.1128/AAC.45.9.2486-2494.20019068211502519Search in Google Scholar

Morgenstern K., Bajler G., Norris D. E., Kraiczy P., Hanssen-Hübner C., Hunfeld K.-P.: In vitro susceptibility of Borreliaspielmanii to microbial agents commonly used for treatment of Lyme disease. Antimicrob. Agents Chemother. 53, 1281–1284 (2009)10.1128/AAC.01247-08265057019075048Search in Google Scholar

Obonyo M., Munderloch U. G., Fingerle V., Wilske B., Kurtti T.J.: Borrelia burgdorferi in tick cell culture modulates expression of outer surface proteins A and C in response to temperature. J. Clin. Microbiol.37, 2137–2141 (1999)10.1128/JCM.37.7.2137-2141.1999Search in Google Scholar

Tylewska-Wierzbanowska S., Chmielewski T.: The isolation of Borrelia burgdorferi spirochetes from clinical material in cel line cultures. Zbl. Bakt.286, 363–370 (1997)10.1016/S0934-8840(97)80094-1Search in Google Scholar

Veinovic G., Cerar T., Strle F., Lotric-Furlan S., Maraspin V., Cimperman J., Ruzic-Sabljic E.: In vitro susceptibility of European human Borrelia burgdorferi sensustricto strains to antimicrobial agents. Int. J. Antimicrob. Agents, 41, 288–291 (2013)10.1016/j.ijantimicag.2012.11.01623312603Search in Google Scholar

Articles recommandés par Trend MD

Planifiez votre conférence à distance avec Sciendo